Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer Chemotherapy

Stephen Frytak,Charles G. Moertel,Judith R. O'fallon,Joseph Rubin,Edward T. Creagan,Michael J. O'connell,Allan J. Schutt, Neal W. Schwartau

Annals of Internal Medicine（2020）

引用 96|浏览9

暂无评分

摘要

Abstract The antiemetic activity and side-effects of delta-9-tetrahydrocannabinol (THC) were evaluated in 116 patients (median age 61 years) receiving combined 5-fluorouracil and semustine (methyl ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要